Online pharmacy Zur Rose improves 2022 core loss target
It is predicted an adjusted core loss (EBITDA) of between 70 million and 75 million Swiss francs ($76.39 million and $81.84 million) in 2022, compared to its previous range of 75 million to 85 million francs.
The company said…